Startups
Our mission at Restore Medical is to provide a unique solution for patients with congestive heart failure (CHF). CHF is one of the leading causes of death and hospitalization, affecting millions worldwide. Patients remain with disabling symptoms despite receiving currently-available optimized medical treatment. To that end, we have developed ContraBand™, a novel catheter-delivered implant which aims to improve CHF patients’ quality-of-life and reduce hospital readmission rates.
Overview
Location
Israel, Tel Aviv District, Or Yehuda
Employees
1-10
Founded date
2019
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 7, 2021 | Restore Medical Announces First in Human Trial for Treatment of Heart Failure in Patients | OR YEHUDA, Israel, Dec. 7, 2021 /PRNewswire/ -- Restore Medical Ltd., a clinical-stage MedTech company developing cardiac implants for the treatment of congestive heart failure (CHF), today announced promising preliminary results of the Fir... |
| Restore Medical | “Revolution In Heart Failure Restore Medical has developed the first and only transcatheter Pulmonary Artery Banding (PAB) system for the treatment of HFrEF patients ContraBand™ is an innovative and reversible therapy for the treatment of l... |
Reviews 0
FAQ about Restore Medical
When was Restore Medical founded?
Restore Medical was founded in 2019.
What has the press written about Restore Medical?
Parsers VC has collected 3 articles mentioning Restore Medical, among them “Restore Medical Announces First in Human Trial for Treatment of Heart Failure in Patients” (Dec 7, 2021) and “Restore Medical”.
Is Restore Medical still active?
Yes, Restore Medical is active; its latest activity on Parsers VC dates from Jul 7, 2025.